Fig. 2: Synergy analysis of BBGC and trabectedin. | Oncogene

Fig. 2: Synergy analysis of BBGC and trabectedin.

From: S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models

Fig. 2

Cell viability percentage in SK-LMS-1 (A) SW872 (B), and HT1080 (C) cells treated with trabectedin or BBGC (left and middle panels). HSA synergy score of BBGC and trabectedin combined treatment in SK-LMS-1 (A), SW872 (B), and HT1080 (C) cells (right panel). The square in the plot indicates the highest synergy area.

Back to article page